Dexamethasone inhibits brain apoptosis in mice with eosinophilic meningitis caused by Angiostrongylus cantonensis infection

Parasites and Vectors

Volumn 8, Issue 1, 2015, Pages

  Tsai, Hung Chin ^a,c   Lee, Bi Yao ^a   Yen, Chuan Min ^b   Wann, Shue Ren ^a   Lee, Susan Shin Jung ^a   Chen, Yao Shen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Angiostrongylus cantonensis; Apoptosis; Blood brain barrier; Corticosteroid; Eosinophilic meningitis

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEXAMETHASONE; EVANS BLUE; PROTEIN BCL 2; IMMUNOLOGIC FACTOR;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HOMOGENATE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHILIC MENINGITIS; IMMUNOHISTOCHEMISTRY; MENINGITIS; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; SUBARACHNOID SPACE; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BRAIN; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; STRONGYLIDA INFECTIONS; TUNEL ASSAY;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALIA; MUS; RATTUS;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; DEXAMETHASONE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; MENINGITIS; MICE; MICE, INBRED BALB C; STRONGYLIDA INFECTIONS;

EID: 84926664375     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-015-0792-7     Document Type: Article

References (35)

1. Beaver PC, Rosen L. Memorandum on the first report of angiostrongylus in man, by Nomura and Lin, 1945. Am J Trop Med Hyg. 1964;13:589-90.
2. Punyagupta S, Juttijudata P, Bunnag T. Eosinophilic meningitis in Thailand: clinical studies of 484 typical cases probably Caused by Angiostrongylus cantonensis. Am J Trop Med Hyg. 1975;24:921-31.
3. Rosen L, Chappell R, Laqueur G. Eosinophilic meningo-encephalitis caused by a metastrongylid lung worm of rats. JAMA. 1962;179:620-4.
4. Yii CY. Clinical observations on eosinophilic meningitis and meningo-encephalitis caused by Angiostrongylus Cantonensis on Taiwan. Am J Trop Med Hyg. 1976;25:233-49.
5. Wen Y. Distribution patterns of Angiostrongylus cantonensis in Achatina fulica. Chinese J Microbiol. 1973;6:1-10.
6. Nishimura K, Mogi M, Okazawa T, Sato Y, Toma H, Wakibe H. Angiostrongylus cantonensis infection in Ampullarium canaliculatus in Kyusu Japan. Southeast Asian J Trop Med Pub Health. 1986;17:595-600.
7. Richards C, Merritt J. Studies on Angiostrongylus cantonensis in molluscan intermediate hosts. J Parasitol. 1967;53:382-8.
8. Yen CM, Chen ER, Cheng CW. A survey of Ampullarium canaliculatus for natural infection of Angiostrongylus cantonensis in south Taiwan. J Trop Med Hyg. 1990;93:347-50.
9. Nye SW, Tangchai P, Sundarakiti S, Punyagupta S. Lesions of the brain in eosinophilic meningitis. Arch Path of Lab Med. 1970;89:9-19.
10. Chen KM, Lee HH, Lai SC, Hsu LS, Wang CJ, Liu JY. Apoptosis in meningo-encephalitis of Angiostrongylus cantonensis-infected mice. Exp Parasitol. 2008;119:385-90.
11. Chotmongkol V, Sawanyawisuth K, Thavornpitak Y. Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis. 2000;31:660-2.
12. Sawanyawisuth K, Limpawattana P, Busaracome P, Ninpaitoon B, Chotmongkol V, Intapan PM, et al. A 1-week course of corticosteroids in the treatment of eosinophilic meningitis. Am J Med. 2004;117:802-3.
13. Lee JD, Tsai LY, Chen CH, Wang JJ, Hsiao JK, Yen CM. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. Acta Trop. 2006;97:204-11.
14. Rosenberg GA, DencoV JE, Correa Jr N, Reiners M, Ford CC. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology. 1996;46:1626-32.
15. Tu WC, Lai SC. Angiostrongylus cantonensis: efficacy of albendazole-dexamethasone co-therapy against infection-induced plasminogen activators and eosinophilic meningitis. Exp Parasitol. 2006;113:8-15.
16. Pien FD, Pien BC. Angiostrongylus cantonensis eosinophilic meningitis. Int J Infect Dis. 1999;3:161-3.
17. Clutterbuck EJ, Sanderson CJ. Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor. Blood. 1990;75:1774-9.
18. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med. 1988;167:219-24.
19. Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338:1592-600.
20. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-57.
21. Wilson NS, Dixit V, Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol. 2009;10:348-55.
22. Lindsay J, Esposti MD, Gilmore AP. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochem Biophys Acta. 1813;2011:532-9.
23. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol. 2005;5:189-200.
24. Friedlander RM, Yuan J. ICE, neuronal apoptosis and neuro-degeneration. Cell Death Differ. 1998;5:823-31.
25. Li M, Ona VO, Chen M, Kaul M, Tenneti L, Zhang X, et al. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience. 2000;99:333-42.
26. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 1993;24:2002-8.
27. Kiechle T, Dedeoglu A, Kubilus J, Kowall NW, Beal MF, Friedlander RM, et al. Cytochrome C and caspase-9 expression in Huntington's disease. Neuromolecular Med. 2002;1:183-95.
28. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002;417:74-8.
29. Emery E, Aldana P, Bunge MB, Puckett W, Srinivasan A, Keane RW, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg. 1998;89:911-20.
30. Meier P, Finch A, Evan G. Apoptosis in development. Nature. 2000;407:796-801.
31. Hu X, Li JH, Lan L, Wu FF, Zhang EP, Song ZM, et al. In vitro study of the effects of Angiostrongylus cantonensis larvae extracts on apoptosis and dysfunction in the blood-brain barrier (BBB). PLoS One. 2012;7(2):e32161.
32. Chuang CC, Chen CW, Fan CK, Su KE, Tsai TY, Chen CL, et al. Angiostrongylus cantonensis: apoptosis of inflammatory cells induced by treatment with mebendazole or/ and interleukin 12 in mice. Exp Parasitol. 2007;115:226-32.
33. Erlacher M, Labi V, Manzl C, Bock G, Tzankov A, Hacker G, et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med. 2006;203:2939-51.
34. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol. 2002;3:932-9.
35. Wüst S, van den Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, et al. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol. 2008;180:8434-43.